Diaceutics PLC (DXRX) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.017x

Based on the latest financial reports, Diaceutics PLC (DXRX) has a cash flow conversion efficiency ratio of 0.017x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX696.00K ≈ $84.68 USD) by net assets (GBX40.48 Million ≈ $4.93K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see DXRX stock market capitalisation for the company's overall valuation and market capitalisation.

Diaceutics PLC - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Diaceutics PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Diaceutics PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Diaceutics PLC ranked by their cash flow conversion efficiency. Explore Diaceutics PLC (DXRX) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
FAT Brands Inc NASDAQ:FATBB	0.024x
Capella Minerals Ltd V:CMIL	0.133x
Current Water Technologies Inc V:WATR	-0.016x
Smtrack Bhd KLSE:0169	0.003x
Jaguar Animal Health Inc NASDAQ:JAGX	-1.085x
Fsport AB ST:FSPORT	-0.057x
Apogee Minerals Ltd V:APMI	0.039x
NEVADA SUNRISE METALS F:K4L	-0.750x

Annual Cash Flow Conversion Efficiency for Diaceutics PLC (2016–2025)

The table below shows the annual cash flow conversion efficiency of Diaceutics PLC from 2016 to 2025. View Diaceutics PLC (DXRX) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	GBX40.48 Million ≈ $4.93K	GBX1.50 Million ≈ $182.02	0.037x	+126.26%
2024-12-31	GBX39.86 Million ≈ $4.85K	GBX651.00K ≈ $79.21	0.016x	-49.19%
2023-12-31	GBX40.79 Million ≈ $4.96K	GBX1.31 Million ≈ $159.51	0.032x	-73.18%
2022-12-31	GBX42.51 Million ≈ $5.17K	GBX5.10 Million ≈ $620.04	0.120x	+754.82%
2021-12-31	GBX40.65 Million ≈ $4.95K	GBX570.00K ≈ $69.35	0.014x	+123.02%
2020-12-31	GBX40.24 Million ≈ $4.90K	GBX253.00K ≈ $30.78	0.006x	+120.19%
2019-12-31	GBX20.13 Million ≈ $2.45K	GBX-627.05K ≈ $-76.29	-0.031x	+91.42%
2018-12-31	GBX2.63 Million ≈ $319.93	GBX-954.04K ≈ $-116.08	-0.363x	-144.41%
2017-12-31	GBX1.88 Million ≈ $228.47	GBX1.53 Million ≈ $186.66	0.817x	+22.70%
2016-12-31	GBX1.01 Million ≈ $123.16	GBX674.01K ≈ $82.01	0.666x	--

About Diaceutics PLC

LSE:DXRX UK Health Information Services

Market Cap

$1.65 Million

GBX13.58 Billion GBX

Market Cap Rank

#30298 Global

#729 in UK

Share Price

GBX160.00

Change (1 day)

+0.00%

52-Week Range

GBX126.50 - GBX176.50

All Time High

GBX187.50